Jayamas Medica Financials
| OMED Stock | 184.00 1.00 0.54% |
Jayamas |
| Foreign Associate | USA |
| Instrument | Indonesia Stock View All |
| Exchange | Jakarta Exchange |
| Business Address | By Pass Krian |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.jmi.co.id |
| Phone | 62 31 898 2349 |
You should never invest in Jayamas Medica without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Jayamas Stock, because this is throwing your money away. Analyzing the key information contained in Jayamas Medica's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Jayamas Medica Key Financial Ratios
Jayamas Medica's financial ratios allow both analysts and investors to convert raw data from Jayamas Medica's financial statements into concise, actionable information that can be used to evaluate the performance of Jayamas Medica over time and compare it to other companies across industries.Jayamas Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Jayamas Medica's current stock value. Our valuation model uses many indicators to compare Jayamas Medica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Jayamas Medica competition to find correlations between indicators driving Jayamas Medica's intrinsic value. More Info.Jayamas Medica Industri is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Jayamas Medica Industri is roughly 1.78 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Jayamas Medica's earnings, one of the primary drivers of an investment's value.Jayamas Medica Industri Systematic Risk
Jayamas Medica's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Jayamas Medica volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was six with a total number of output elements of fifty-five. The Beta measures systematic risk based on how returns on Jayamas Medica Industri correlated with the market. If Beta is less than 0 Jayamas Medica generally moves in the opposite direction as compared to the market. If Jayamas Medica Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Jayamas Medica Industri is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Jayamas Medica is generally in the same direction as the market. If Beta > 1 Jayamas Medica moves generally in the same direction as, but more than the movement of the benchmark.
Jayamas Medica January 8, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Jayamas Medica help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Jayamas Medica Industri. We use our internally-developed statistical techniques to arrive at the intrinsic value of Jayamas Medica Industri based on widely used predictive technical indicators. In general, we focus on analyzing Jayamas Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Jayamas Medica's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.09 | |||
| Information Ratio | 0.0348 | |||
| Maximum Drawdown | 9.48 | |||
| Value At Risk | (1.66) | |||
| Potential Upside | 2.29 |
Other Information on Investing in Jayamas Stock
Jayamas Medica financial ratios help investors to determine whether Jayamas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jayamas with respect to the benefits of owning Jayamas Medica security.